📘February issue now available➡️https://t.co/2cQ7Mny3xv This issue explores psychotropic medicines in people with cognitive disability or impairment, ADHD management in adults, and more! #healthcare#freejournal#independentpeerreview
🎈Join Laura Beaton and Danielle Mazza, a GP specialist in women’s sexual and reproductive health, as they discuss nonsurgical diagnostic approaches, early treatment and the implications of recognising endometriosis as a chronic condition. Listen now: https://t.co/gUovT0h17K
🎧 What has changed in the management of acute #hyperkalaemia?
Jo Cheah speaks to clinical pharmacist Samuel Ford about the presentation and diagnosis of acute hyperkalaemia. Listen now: https://t.co/5f8at0gqgZ #healthcarepodcast
🫀Cardiac #amyloidosis is an under-recognised but treatable cause of heart failure. Early recognition is key to timely investigation and referral for disease-modifying therapies. Learn how to recognise the key clinical features of cardiac amyloidosis. 🔗 https://t.co/EhDxjxJh59
💡As nursing’s professional scope of practice evolves, how do we expand access while staying patient-centred? Dr Jane Currie shares her perspective on the designated prescriber RN role and the future health care workforce. 👉 https://t.co/k7XdLKr6Sc
#HealthPolicy#Nursing
#Endometriosis and #adenomyosis are common chronic gynaecological conditions. Recently updated Australian guidelines support clinical diagnosis and early management in primary care without the need for surgical confirmation. Learn more👉 https://t.co/6DTAOQuUVc
What’s new in #glaucoma management in adults? Laura Beaton talks to ophthalmologist Alp Atik about the types of glaucoma, screening, and treatments to lower intraocular pressure, the only proven strategy to slow disease progression.
🎧Listen now: https://t.co/ai3eWFKMFd
📊 Approximately 227,000 people are living with chronic #hepatitisB in Australia, yet 1 in 3 are undiagnosed. Recent changes include population-wide testing and expanded access to hepatitis B prescribing in primary care. Learn more in this article. 👉 https://t.co/tLzt58qAqd
🎧Justin Coleman chats with sexual health specialist Manoji Gunathilake about the resurgence of syphilis in Australia, the importance of testing and priority populations, and interpretation of laboratory results. Listen now.👉https://t.co/7PCKSswx1e
📖 The October issue of Australian Prescriber is out now!
This issue highlights major shifts in the diagnosis and treatment of hepatitis B, endometriosis, cardiac amyloidosis and multiple myeloma, and more!
👉Explore the latest issue: https://t.co/MDA6lOPT4y
🫀What’s the latest antibiotic treatment advice for Strep A skin and throat infections? 🎧 Laura Beaton speaks with cardiologist James Marangou about key updates to the Australian guideline for rheumatic fever and rheumatic heart disease. Listen now: https://t.co/zZyyqD1Wpt
🪞How can acne vulgaris be treated effectively? Jo Cheah speaks with dermatologist Belinda Welsh about treatment options, practical skincare and long-term adherence to reduce scarring and mental health impacts. Listen now to find out more: https://t.co/katM9z2oeR
#AcneVulgaris
🦷 What has changed in antibiotic prophylaxis for dental procedures? Dhineli Perera speaks with dentist Smitha Sukumar about the updated recommendations in Therapeutic Guidelines: Oral and Dental. Listen now: https://t.co/7iCpGrIGci
Read the full article : https://t.co/XAzlExLiia
🚨UPDATE: Early effective treatment of acne vulgaris reduces the risk of scarring and mental health impacts. The approach to acne treatment has changed. This article provides an update on topical and oral therapies for acne. ✨Read now: https://t.co/8HK64m8IjV
#acnetreatment
Rheumatic heart disease is the most common cause of acquired childhood cardiac disease globally. Updated clinical guidelines for prevention and management of #rheumaticfever and rheumatic #heartdisease were released in 2025. Read our independent review: 👉https://t.co/TENamQCQLP
🔎 How should acute COVID-19 be managed in the community, and who stands to benefit most from antiviral treatment? ID physician Joshua Davis talks through the risk factors, the evidence, and the patients most likely to benefit. Listen now➡️ https://t.co/x7TCyHeyWG
There has been a resurgence of #syphilis in recent years, including sexually transmitted and congenital syphilis. Prevalence can be reduced by increasing testing, effective treatment and contact tracing.
Learn more: 👉 https://t.co/KHm8yy6YNY
#congenitalsyphilis#STItesting
📖 NEW: Learn about the latest recommendations for assessment and treatment of acute COVID-19 in the community.👉 https://t.co/vfz52KrGKe
#COVID19#antivirals#nirmaltervir#molnupiravir
The August issue of #AustralianPrescriber features updates on community treatment of acute COVID-19, syphilis testing and treatment, rheumatic fever and rheumatic heart disease, acne vulgaris, and dental antibiotic prophylaxis, plus new drug summaries. 👉 https://t.co/cX3lJbOvhg
📢 Australian Prescriber is proud to partner with the Pharmaceutical Society of Australia to help #pharmacists across Australia stay current with independent, evidence-based and accredited continuing professional development (CPD).
Learn more: https://t.co/qHHLFKPddp #healthcare
⚠️ Sodium valproate's prescribing landscape is changing. What do clinicians need to know about its benefits, risks and place in practice? 🎧 Dhineli Perera speaks with neurologist Dan McLaughlin. Listen here: https://t.co/rn6nc7JfVs
#SodiumValproate#Epilepsy#Neurology